nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—CYP3A4—bone cancer	0.306	1	CbGaD
Progesterone—ABCC1—Epirubicin—bone cancer	0.0824	0.196	CbGbCtD
Progesterone—ABCB11—Doxorubicin—bone cancer	0.0617	0.147	CbGbCtD
Progesterone—CYP1B1—Doxorubicin—bone cancer	0.0617	0.147	CbGbCtD
Progesterone—SLC22A2—Cisplatin—bone cancer	0.0593	0.141	CbGbCtD
Progesterone—ABCC1—Doxorubicin—bone cancer	0.0438	0.104	CbGbCtD
Progesterone—ABCC1—Methotrexate—bone cancer	0.0424	0.101	CbGbCtD
Progesterone—CYP2C9—Cisplatin—bone cancer	0.0163	0.0387	CbGbCtD
Progesterone—ABCB1—Cisplatin—bone cancer	0.0158	0.0375	CbGbCtD
Progesterone—ABCB1—Doxorubicin—bone cancer	0.0106	0.0251	CbGbCtD
Progesterone—ABCB1—Methotrexate—bone cancer	0.0102	0.0244	CbGbCtD
Progesterone—CYP2D6—Doxorubicin—bone cancer	0.00996	0.0237	CbGbCtD
Progesterone—CYP3A4—Doxorubicin—bone cancer	0.00633	0.0151	CbGbCtD
Progesterone—Finasteride—CYP3A4—bone cancer	0.000456	0.115	CrCbGaD
Progesterone—Hydrocortamate—CYP3A4—bone cancer	0.000452	0.114	CrCbGaD
Progesterone—Cortisone acetate—CYP3A4—bone cancer	0.000445	0.112	CrCbGaD
Progesterone—Eplerenone—CYP3A4—bone cancer	0.000391	0.0984	CrCbGaD
Progesterone—Drospirenone—PTGS2—bone cancer	0.000367	0.0923	CrCbGaD
Progesterone—Levonorgestrel—CYP3A4—bone cancer	0.000306	0.077	CrCbGaD
Progesterone—Danazol—CYP3A4—bone cancer	0.000278	0.0701	CrCbGaD
Progesterone—Medroxyprogesterone Acetate—CYP3A4—bone cancer	0.00025	0.0629	CrCbGaD
Progesterone—Norethindrone—CYP3A4—bone cancer	0.000248	0.0624	CrCbGaD
Progesterone—Methyltestosterone—CYP3A4—bone cancer	0.000235	0.0592	CrCbGaD
Progesterone—Prednisolone—CYP3A4—bone cancer	0.000232	0.0583	CrCbGaD
Progesterone—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000186	0.00126	CcSEcCtD
Progesterone—Haemoglobin—Methotrexate—bone cancer	0.000186	0.00126	CcSEcCtD
Progesterone—Haemorrhage—Methotrexate—bone cancer	0.000185	0.00126	CcSEcCtD
Progesterone—Hepatitis—Methotrexate—bone cancer	0.000185	0.00126	CcSEcCtD
Progesterone—Pollakiuria—Doxorubicin—bone cancer	0.000185	0.00125	CcSEcCtD
Progesterone—Pharyngitis—Methotrexate—bone cancer	0.000184	0.00125	CcSEcCtD
Progesterone—Urinary tract disorder—Methotrexate—bone cancer	0.000183	0.00124	CcSEcCtD
Progesterone—Hepatobiliary disease—Epirubicin—bone cancer	0.000182	0.00124	CcSEcCtD
Progesterone—Weight increased—Doxorubicin—bone cancer	0.000182	0.00124	CcSEcCtD
Progesterone—Urethral disorder—Methotrexate—bone cancer	0.000181	0.00123	CcSEcCtD
Progesterone—Weight decreased—Doxorubicin—bone cancer	0.000181	0.00123	CcSEcCtD
Progesterone—Sinusitis—Epirubicin—bone cancer	0.000181	0.00123	CcSEcCtD
Progesterone—Hyperglycaemia—Doxorubicin—bone cancer	0.000181	0.00122	CcSEcCtD
Progesterone—Pneumonia—Doxorubicin—bone cancer	0.000179	0.00122	CcSEcCtD
Progesterone—Infestation NOS—Doxorubicin—bone cancer	0.000178	0.00121	CcSEcCtD
Progesterone—Infestation—Doxorubicin—bone cancer	0.000178	0.00121	CcSEcCtD
Progesterone—Drowsiness—Doxorubicin—bone cancer	0.000178	0.00121	CcSEcCtD
Progesterone—Visual impairment—Methotrexate—bone cancer	0.000178	0.00121	CcSEcCtD
Progesterone—Hydrocortisone—CYP3A4—bone cancer	0.000177	0.0446	CrCbGaD
Progesterone—Hypersensitivity—Cisplatin—bone cancer	0.000176	0.0012	CcSEcCtD
Progesterone—Erythema multiforme—Methotrexate—bone cancer	0.000175	0.00119	CcSEcCtD
Progesterone—Neuropathy peripheral—Doxorubicin—bone cancer	0.000175	0.00119	CcSEcCtD
Progesterone—Haemoglobin—Epirubicin—bone cancer	0.000174	0.00118	CcSEcCtD
Progesterone—Jaundice—Doxorubicin—bone cancer	0.000174	0.00118	CcSEcCtD
Progesterone—Rhinitis—Epirubicin—bone cancer	0.000174	0.00118	CcSEcCtD
Progesterone—Conjunctivitis—Doxorubicin—bone cancer	0.000173	0.00118	CcSEcCtD
Progesterone—Urinary tract infection—Doxorubicin—bone cancer	0.000173	0.00118	CcSEcCtD
Progesterone—Hepatitis—Epirubicin—bone cancer	0.000173	0.00117	CcSEcCtD
Progesterone—Haemorrhage—Epirubicin—bone cancer	0.000173	0.00117	CcSEcCtD
Progesterone—Eye disorder—Methotrexate—bone cancer	0.000173	0.00117	CcSEcCtD
Progesterone—Tinnitus—Methotrexate—bone cancer	0.000172	0.00117	CcSEcCtD
Progesterone—Asthenia—Cisplatin—bone cancer	0.000172	0.00117	CcSEcCtD
Progesterone—Pharyngitis—Epirubicin—bone cancer	0.000172	0.00117	CcSEcCtD
Progesterone—Cardiac disorder—Methotrexate—bone cancer	0.000172	0.00116	CcSEcCtD
Progesterone—Urinary tract disorder—Epirubicin—bone cancer	0.000171	0.00116	CcSEcCtD
Progesterone—Oedema peripheral—Epirubicin—bone cancer	0.000171	0.00116	CcSEcCtD
Progesterone—Connective tissue disorder—Epirubicin—bone cancer	0.00017	0.00115	CcSEcCtD
Progesterone—Urethral disorder—Epirubicin—bone cancer	0.00017	0.00115	CcSEcCtD
Progesterone—Hepatobiliary disease—Doxorubicin—bone cancer	0.000169	0.00114	CcSEcCtD
Progesterone—Angiopathy—Methotrexate—bone cancer	0.000168	0.00114	CcSEcCtD
Progesterone—Sinusitis—Doxorubicin—bone cancer	0.000167	0.00114	CcSEcCtD
Progesterone—Immune system disorder—Methotrexate—bone cancer	0.000167	0.00113	CcSEcCtD
Progesterone—Visual impairment—Epirubicin—bone cancer	0.000167	0.00113	CcSEcCtD
Progesterone—Mediastinal disorder—Methotrexate—bone cancer	0.000167	0.00113	CcSEcCtD
Progesterone—Diarrhoea—Cisplatin—bone cancer	0.000164	0.00111	CcSEcCtD
Progesterone—Erythema multiforme—Epirubicin—bone cancer	0.000164	0.00111	CcSEcCtD
Progesterone—Alopecia—Methotrexate—bone cancer	0.000163	0.00111	CcSEcCtD
Progesterone—Mental disorder—Methotrexate—bone cancer	0.000162	0.0011	CcSEcCtD
Progesterone—Eye disorder—Epirubicin—bone cancer	0.000162	0.0011	CcSEcCtD
Progesterone—Tinnitus—Epirubicin—bone cancer	0.000161	0.0011	CcSEcCtD
Progesterone—Malnutrition—Methotrexate—bone cancer	0.000161	0.00109	CcSEcCtD
Progesterone—Erythema—Methotrexate—bone cancer	0.000161	0.00109	CcSEcCtD
Progesterone—Haemoglobin—Doxorubicin—bone cancer	0.000161	0.00109	CcSEcCtD
Progesterone—Cardiac disorder—Epirubicin—bone cancer	0.000161	0.00109	CcSEcCtD
Progesterone—Rhinitis—Doxorubicin—bone cancer	0.000161	0.00109	CcSEcCtD
Progesterone—Hepatitis—Doxorubicin—bone cancer	0.00016	0.00109	CcSEcCtD
Progesterone—Haemorrhage—Doxorubicin—bone cancer	0.00016	0.00109	CcSEcCtD
Progesterone—Pharyngitis—Doxorubicin—bone cancer	0.000159	0.00108	CcSEcCtD
Progesterone—Urinary tract disorder—Doxorubicin—bone cancer	0.000158	0.00107	CcSEcCtD
Progesterone—Oedema peripheral—Doxorubicin—bone cancer	0.000158	0.00107	CcSEcCtD
Progesterone—Connective tissue disorder—Doxorubicin—bone cancer	0.000157	0.00107	CcSEcCtD
Progesterone—Angiopathy—Epirubicin—bone cancer	0.000157	0.00107	CcSEcCtD
Progesterone—Urethral disorder—Doxorubicin—bone cancer	0.000157	0.00107	CcSEcCtD
Progesterone—Immune system disorder—Epirubicin—bone cancer	0.000156	0.00106	CcSEcCtD
Progesterone—Mediastinal disorder—Epirubicin—bone cancer	0.000156	0.00106	CcSEcCtD
Progesterone—Back pain—Methotrexate—bone cancer	0.000156	0.00106	CcSEcCtD
Progesterone—Visual impairment—Doxorubicin—bone cancer	0.000154	0.00105	CcSEcCtD
Progesterone—Alopecia—Epirubicin—bone cancer	0.000153	0.00104	CcSEcCtD
Progesterone—Vomiting—Cisplatin—bone cancer	0.000152	0.00103	CcSEcCtD
Progesterone—Vision blurred—Methotrexate—bone cancer	0.000152	0.00103	CcSEcCtD
Progesterone—Mental disorder—Epirubicin—bone cancer	0.000152	0.00103	CcSEcCtD
Progesterone—Erythema multiforme—Doxorubicin—bone cancer	0.000151	0.00103	CcSEcCtD
Progesterone—Rash—Cisplatin—bone cancer	0.000151	0.00102	CcSEcCtD
Progesterone—Dermatitis—Cisplatin—bone cancer	0.000151	0.00102	CcSEcCtD
Progesterone—Erythema—Epirubicin—bone cancer	0.000151	0.00102	CcSEcCtD
Progesterone—Malnutrition—Epirubicin—bone cancer	0.000151	0.00102	CcSEcCtD
Progesterone—Eye disorder—Doxorubicin—bone cancer	0.00015	0.00102	CcSEcCtD
Progesterone—Ill-defined disorder—Methotrexate—bone cancer	0.000149	0.00101	CcSEcCtD
Progesterone—Tinnitus—Doxorubicin—bone cancer	0.000149	0.00101	CcSEcCtD
Progesterone—Anaemia—Methotrexate—bone cancer	0.000149	0.00101	CcSEcCtD
Progesterone—Cardiac disorder—Doxorubicin—bone cancer	0.000149	0.00101	CcSEcCtD
Progesterone—Flatulence—Epirubicin—bone cancer	0.000149	0.00101	CcSEcCtD
Progesterone—Tension—Epirubicin—bone cancer	0.000148	0.001	CcSEcCtD
Progesterone—Nervousness—Epirubicin—bone cancer	0.000146	0.000993	CcSEcCtD
Progesterone—Back pain—Epirubicin—bone cancer	0.000146	0.000989	CcSEcCtD
Progesterone—Angiopathy—Doxorubicin—bone cancer	0.000145	0.000986	CcSEcCtD
Progesterone—Malaise—Methotrexate—bone cancer	0.000145	0.000985	CcSEcCtD
Progesterone—Muscle spasms—Epirubicin—bone cancer	0.000145	0.000983	CcSEcCtD
Progesterone—Immune system disorder—Doxorubicin—bone cancer	0.000145	0.000982	CcSEcCtD
Progesterone—Vertigo—Methotrexate—bone cancer	0.000145	0.000982	CcSEcCtD
Progesterone—Mediastinal disorder—Doxorubicin—bone cancer	0.000144	0.000979	CcSEcCtD
Progesterone—Nausea—Cisplatin—bone cancer	0.000142	0.000965	CcSEcCtD
Progesterone—Vision blurred—Epirubicin—bone cancer	0.000142	0.000964	CcSEcCtD
Progesterone—Alopecia—Doxorubicin—bone cancer	0.000142	0.00096	CcSEcCtD
Progesterone—Cough—Methotrexate—bone cancer	0.000141	0.000953	CcSEcCtD
Progesterone—Mental disorder—Doxorubicin—bone cancer	0.00014	0.000952	CcSEcCtD
Progesterone—Ill-defined disorder—Epirubicin—bone cancer	0.00014	0.000949	CcSEcCtD
Progesterone—Convulsion—Methotrexate—bone cancer	0.00014	0.000947	CcSEcCtD
Progesterone—Erythema—Doxorubicin—bone cancer	0.000139	0.000946	CcSEcCtD
Progesterone—Malnutrition—Doxorubicin—bone cancer	0.000139	0.000946	CcSEcCtD
Progesterone—Anaemia—Epirubicin—bone cancer	0.000139	0.000945	CcSEcCtD
Progesterone—Flatulence—Doxorubicin—bone cancer	0.000137	0.000932	CcSEcCtD
Progesterone—Arthralgia—Methotrexate—bone cancer	0.000137	0.00093	CcSEcCtD
Progesterone—Chest pain—Methotrexate—bone cancer	0.000137	0.00093	CcSEcCtD
Progesterone—Myalgia—Methotrexate—bone cancer	0.000137	0.00093	CcSEcCtD
Progesterone—Tension—Doxorubicin—bone cancer	0.000137	0.000928	CcSEcCtD
Progesterone—Testosterone—CYP3A4—bone cancer	0.000136	0.0344	CrCbGaD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000136	0.000924	CcSEcCtD
Progesterone—Malaise—Epirubicin—bone cancer	0.000136	0.000922	CcSEcCtD
Progesterone—Discomfort—Methotrexate—bone cancer	0.000135	0.000919	CcSEcCtD
Progesterone—Nervousness—Doxorubicin—bone cancer	0.000135	0.000919	CcSEcCtD
Progesterone—Vertigo—Epirubicin—bone cancer	0.000135	0.000919	CcSEcCtD
Progesterone—Syncope—Epirubicin—bone cancer	0.000135	0.000917	CcSEcCtD
Progesterone—Back pain—Doxorubicin—bone cancer	0.000135	0.000915	CcSEcCtD
Progesterone—Muscle spasms—Doxorubicin—bone cancer	0.000134	0.00091	CcSEcCtD
Progesterone—Palpitations—Epirubicin—bone cancer	0.000133	0.000904	CcSEcCtD
Progesterone—Confusional state—Methotrexate—bone cancer	0.000133	0.000899	CcSEcCtD
Progesterone—Loss of consciousness—Epirubicin—bone cancer	0.000132	0.000899	CcSEcCtD
Progesterone—Cough—Epirubicin—bone cancer	0.000132	0.000892	CcSEcCtD
Progesterone—Anaphylactic shock—Methotrexate—bone cancer	0.000131	0.000892	CcSEcCtD
Progesterone—Vision blurred—Doxorubicin—bone cancer	0.000131	0.000892	CcSEcCtD
Progesterone—Convulsion—Epirubicin—bone cancer	0.000131	0.000886	CcSEcCtD
Progesterone—Infection—Methotrexate—bone cancer	0.000131	0.000886	CcSEcCtD
Progesterone—Hypertension—Epirubicin—bone cancer	0.00013	0.000883	CcSEcCtD
Progesterone—Ill-defined disorder—Doxorubicin—bone cancer	0.000129	0.000878	CcSEcCtD
Progesterone—Nervous system disorder—Methotrexate—bone cancer	0.000129	0.000874	CcSEcCtD
Progesterone—Anaemia—Doxorubicin—bone cancer	0.000129	0.000874	CcSEcCtD
Progesterone—Arthralgia—Epirubicin—bone cancer	0.000128	0.00087	CcSEcCtD
Progesterone—Chest pain—Epirubicin—bone cancer	0.000128	0.00087	CcSEcCtD
Progesterone—Myalgia—Epirubicin—bone cancer	0.000128	0.00087	CcSEcCtD
Progesterone—Anxiety—Epirubicin—bone cancer	0.000128	0.000867	CcSEcCtD
Progesterone—Skin disorder—Methotrexate—bone cancer	0.000128	0.000866	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000127	0.000864	CcSEcCtD
Progesterone—Hyperhidrosis—Methotrexate—bone cancer	0.000127	0.000862	CcSEcCtD
Progesterone—Discomfort—Epirubicin—bone cancer	0.000127	0.00086	CcSEcCtD
Progesterone—Malaise—Doxorubicin—bone cancer	0.000126	0.000853	CcSEcCtD
Progesterone—Dry mouth—Epirubicin—bone cancer	0.000125	0.000851	CcSEcCtD
Progesterone—Vertigo—Doxorubicin—bone cancer	0.000125	0.00085	CcSEcCtD
Progesterone—Anorexia—Methotrexate—bone cancer	0.000125	0.00085	CcSEcCtD
Progesterone—Syncope—Doxorubicin—bone cancer	0.000125	0.000848	CcSEcCtD
Progesterone—Confusional state—Epirubicin—bone cancer	0.000124	0.000841	CcSEcCtD
Progesterone—Palpitations—Doxorubicin—bone cancer	0.000123	0.000836	CcSEcCtD
Progesterone—Anaphylactic shock—Epirubicin—bone cancer	0.000123	0.000834	CcSEcCtD
Progesterone—Oedema—Epirubicin—bone cancer	0.000123	0.000834	CcSEcCtD
Progesterone—Hypotension—Methotrexate—bone cancer	0.000123	0.000833	CcSEcCtD
Progesterone—Loss of consciousness—Doxorubicin—bone cancer	0.000123	0.000831	CcSEcCtD
Progesterone—Infection—Epirubicin—bone cancer	0.000122	0.000829	CcSEcCtD
Progesterone—Cough—Doxorubicin—bone cancer	0.000122	0.000826	CcSEcCtD
Progesterone—Shock—Epirubicin—bone cancer	0.000121	0.000821	CcSEcCtD
Progesterone—Convulsion—Doxorubicin—bone cancer	0.000121	0.00082	CcSEcCtD
Progesterone—Nervous system disorder—Epirubicin—bone cancer	0.000121	0.000818	CcSEcCtD
Progesterone—Hypertension—Doxorubicin—bone cancer	0.00012	0.000817	CcSEcCtD
Progesterone—Tachycardia—Epirubicin—bone cancer	0.00012	0.000814	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00012	0.000812	CcSEcCtD
Progesterone—Skin disorder—Epirubicin—bone cancer	0.000119	0.000811	CcSEcCtD
Progesterone—Hyperhidrosis—Epirubicin—bone cancer	0.000119	0.000807	CcSEcCtD
Progesterone—Insomnia—Methotrexate—bone cancer	0.000119	0.000806	CcSEcCtD
Progesterone—Chest pain—Doxorubicin—bone cancer	0.000119	0.000805	CcSEcCtD
Progesterone—Myalgia—Doxorubicin—bone cancer	0.000119	0.000805	CcSEcCtD
Progesterone—Arthralgia—Doxorubicin—bone cancer	0.000119	0.000805	CcSEcCtD
Progesterone—Anxiety—Doxorubicin—bone cancer	0.000118	0.000803	CcSEcCtD
Progesterone—Paraesthesia—Methotrexate—bone cancer	0.000118	0.000801	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000118	0.0008	CcSEcCtD
Progesterone—Discomfort—Doxorubicin—bone cancer	0.000117	0.000796	CcSEcCtD
Progesterone—Anorexia—Epirubicin—bone cancer	0.000117	0.000795	CcSEcCtD
Progesterone—Dyspnoea—Methotrexate—bone cancer	0.000117	0.000795	CcSEcCtD
Progesterone—Somnolence—Methotrexate—bone cancer	0.000117	0.000793	CcSEcCtD
Progesterone—Dry mouth—Doxorubicin—bone cancer	0.000116	0.000788	CcSEcCtD
Progesterone—Dyspepsia—Methotrexate—bone cancer	0.000116	0.000785	CcSEcCtD
Progesterone—Hypotension—Epirubicin—bone cancer	0.000115	0.00078	CcSEcCtD
Progesterone—Confusional state—Doxorubicin—bone cancer	0.000115	0.000779	CcSEcCtD
Progesterone—Decreased appetite—Methotrexate—bone cancer	0.000114	0.000775	CcSEcCtD
Progesterone—Anaphylactic shock—Doxorubicin—bone cancer	0.000114	0.000772	CcSEcCtD
Progesterone—Oedema—Doxorubicin—bone cancer	0.000114	0.000772	CcSEcCtD
Progesterone—Gastrointestinal disorder—Methotrexate—bone cancer	0.000113	0.00077	CcSEcCtD
Progesterone—Fatigue—Methotrexate—bone cancer	0.000113	0.000769	CcSEcCtD
Progesterone—Infection—Doxorubicin—bone cancer	0.000113	0.000767	CcSEcCtD
Progesterone—Pain—Methotrexate—bone cancer	0.000112	0.000762	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000112	0.00076	CcSEcCtD
Progesterone—Shock—Doxorubicin—bone cancer	0.000112	0.00076	CcSEcCtD
Progesterone—Nervous system disorder—Doxorubicin—bone cancer	0.000112	0.000757	CcSEcCtD
Progesterone—Insomnia—Epirubicin—bone cancer	0.000111	0.000755	CcSEcCtD
Progesterone—Tachycardia—Doxorubicin—bone cancer	0.000111	0.000754	CcSEcCtD
Progesterone—Skin disorder—Doxorubicin—bone cancer	0.000111	0.00075	CcSEcCtD
Progesterone—Paraesthesia—Epirubicin—bone cancer	0.00011	0.000749	CcSEcCtD
Progesterone—Hyperhidrosis—Doxorubicin—bone cancer	0.00011	0.000746	CcSEcCtD
Progesterone—Dyspnoea—Epirubicin—bone cancer	0.00011	0.000744	CcSEcCtD
Progesterone—Somnolence—Epirubicin—bone cancer	0.000109	0.000742	CcSEcCtD
Progesterone—Anorexia—Doxorubicin—bone cancer	0.000108	0.000736	CcSEcCtD
Progesterone—Feeling abnormal—Methotrexate—bone cancer	0.000108	0.000735	CcSEcCtD
Progesterone—Dyspepsia—Epirubicin—bone cancer	0.000108	0.000735	CcSEcCtD
Progesterone—Gastrointestinal pain—Methotrexate—bone cancer	0.000107	0.000729	CcSEcCtD
Progesterone—Decreased appetite—Epirubicin—bone cancer	0.000107	0.000725	CcSEcCtD
Progesterone—Hypotension—Doxorubicin—bone cancer	0.000106	0.000721	CcSEcCtD
Progesterone—Gastrointestinal disorder—Epirubicin—bone cancer	0.000106	0.00072	CcSEcCtD
Progesterone—Fatigue—Epirubicin—bone cancer	0.000106	0.000719	CcSEcCtD
Progesterone—Pain—Epirubicin—bone cancer	0.000105	0.000714	CcSEcCtD
Progesterone—Constipation—Epirubicin—bone cancer	0.000105	0.000714	CcSEcCtD
Progesterone—Urticaria—Methotrexate—bone cancer	0.000104	0.000708	CcSEcCtD
Progesterone—Abdominal pain—Methotrexate—bone cancer	0.000104	0.000705	CcSEcCtD
Progesterone—Body temperature increased—Methotrexate—bone cancer	0.000104	0.000705	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000104	0.000703	CcSEcCtD
Progesterone—Insomnia—Doxorubicin—bone cancer	0.000103	0.000698	CcSEcCtD
Progesterone—Paraesthesia—Doxorubicin—bone cancer	0.000102	0.000693	CcSEcCtD
Progesterone—Dyspnoea—Doxorubicin—bone cancer	0.000101	0.000688	CcSEcCtD
Progesterone—Feeling abnormal—Epirubicin—bone cancer	0.000101	0.000688	CcSEcCtD
Progesterone—Somnolence—Doxorubicin—bone cancer	0.000101	0.000686	CcSEcCtD
Progesterone—Gastrointestinal pain—Epirubicin—bone cancer	0.000101	0.000682	CcSEcCtD
Progesterone—Dyspepsia—Doxorubicin—bone cancer	0.0001	0.00068	CcSEcCtD
Progesterone—Decreased appetite—Doxorubicin—bone cancer	9.89e-05	0.000671	CcSEcCtD
Progesterone—Gastrointestinal disorder—Doxorubicin—bone cancer	9.83e-05	0.000667	CcSEcCtD
Progesterone—Fatigue—Doxorubicin—bone cancer	9.81e-05	0.000666	CcSEcCtD
Progesterone—Urticaria—Epirubicin—bone cancer	9.77e-05	0.000663	CcSEcCtD
Progesterone—Pain—Doxorubicin—bone cancer	9.73e-05	0.00066	CcSEcCtD
Progesterone—Constipation—Doxorubicin—bone cancer	9.73e-05	0.00066	CcSEcCtD
Progesterone—Body temperature increased—Epirubicin—bone cancer	9.72e-05	0.00066	CcSEcCtD
Progesterone—Abdominal pain—Epirubicin—bone cancer	9.72e-05	0.00066	CcSEcCtD
Progesterone—Hypersensitivity—Methotrexate—bone cancer	9.68e-05	0.000657	CcSEcCtD
Progesterone—Asthenia—Methotrexate—bone cancer	9.43e-05	0.00064	CcSEcCtD
Progesterone—Feeling abnormal—Doxorubicin—bone cancer	9.38e-05	0.000636	CcSEcCtD
Progesterone—Gastrointestinal pain—Doxorubicin—bone cancer	9.31e-05	0.000631	CcSEcCtD
Progesterone—Pruritus—Methotrexate—bone cancer	9.3e-05	0.000631	CcSEcCtD
Progesterone—Hypersensitivity—Epirubicin—bone cancer	9.06e-05	0.000615	CcSEcCtD
Progesterone—Urticaria—Doxorubicin—bone cancer	9.04e-05	0.000613	CcSEcCtD
Progesterone—Abdominal pain—Doxorubicin—bone cancer	9e-05	0.00061	CcSEcCtD
Progesterone—Body temperature increased—Doxorubicin—bone cancer	9e-05	0.00061	CcSEcCtD
Progesterone—Diarrhoea—Methotrexate—bone cancer	8.99e-05	0.00061	CcSEcCtD
Progesterone—Asthenia—Epirubicin—bone cancer	8.83e-05	0.000599	CcSEcCtD
Progesterone—Pruritus—Epirubicin—bone cancer	8.7e-05	0.00059	CcSEcCtD
Progesterone—Dizziness—Methotrexate—bone cancer	8.69e-05	0.00059	CcSEcCtD
Progesterone—Diarrhoea—Epirubicin—bone cancer	8.42e-05	0.000571	CcSEcCtD
Progesterone—Hypersensitivity—Doxorubicin—bone cancer	8.39e-05	0.000569	CcSEcCtD
Progesterone—Vomiting—Methotrexate—bone cancer	8.36e-05	0.000567	CcSEcCtD
Progesterone—Rash—Methotrexate—bone cancer	8.29e-05	0.000562	CcSEcCtD
Progesterone—Dermatitis—Methotrexate—bone cancer	8.28e-05	0.000562	CcSEcCtD
Progesterone—Headache—Methotrexate—bone cancer	8.23e-05	0.000559	CcSEcCtD
Progesterone—Asthenia—Doxorubicin—bone cancer	8.17e-05	0.000554	CcSEcCtD
Progesterone—Dizziness—Epirubicin—bone cancer	8.13e-05	0.000552	CcSEcCtD
Progesterone—Pruritus—Doxorubicin—bone cancer	8.05e-05	0.000546	CcSEcCtD
Progesterone—Vomiting—Epirubicin—bone cancer	7.82e-05	0.000531	CcSEcCtD
Progesterone—Nausea—Methotrexate—bone cancer	7.81e-05	0.00053	CcSEcCtD
Progesterone—Diarrhoea—Doxorubicin—bone cancer	7.79e-05	0.000528	CcSEcCtD
Progesterone—Rash—Epirubicin—bone cancer	7.76e-05	0.000526	CcSEcCtD
Progesterone—Dermatitis—Epirubicin—bone cancer	7.75e-05	0.000526	CcSEcCtD
Progesterone—Headache—Epirubicin—bone cancer	7.71e-05	0.000523	CcSEcCtD
Progesterone—Dizziness—Doxorubicin—bone cancer	7.53e-05	0.000511	CcSEcCtD
Progesterone—Nausea—Epirubicin—bone cancer	7.31e-05	0.000496	CcSEcCtD
Progesterone—Vomiting—Doxorubicin—bone cancer	7.24e-05	0.000491	CcSEcCtD
Progesterone—Rash—Doxorubicin—bone cancer	7.18e-05	0.000487	CcSEcCtD
Progesterone—Dermatitis—Doxorubicin—bone cancer	7.17e-05	0.000486	CcSEcCtD
Progesterone—Headache—Doxorubicin—bone cancer	7.13e-05	0.000484	CcSEcCtD
Progesterone—Nausea—Doxorubicin—bone cancer	6.76e-05	0.000459	CcSEcCtD
Progesterone—ESR1—Integrated Breast Cancer Pathway—JUN—bone cancer	5.25e-05	0.000431	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—NT5C3A—bone cancer	5.23e-05	0.000429	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	5.2e-05	0.000427	CbGpPWpGaD
Progesterone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	5.1e-05	0.000418	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—CYP3A4—bone cancer	5.09e-05	0.000418	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.06e-05	0.000416	CbGpPWpGaD
Progesterone—CYP2D6—Biological oxidations—GSTP1—bone cancer	5.05e-05	0.000415	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—JUN—bone cancer	5.04e-05	0.000414	CbGpPWpGaD
Progesterone—CYP2C9—Biological oxidations—GSTP1—bone cancer	5.01e-05	0.000411	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	5.01e-05	0.000411	CbGpPWpGaD
Progesterone—CYP1A2—Biological oxidations—CYP3A4—bone cancer	5e-05	0.000411	CbGpPWpGaD
Progesterone—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	4.98e-05	0.000409	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—NDUFA12—bone cancer	4.98e-05	0.000409	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—GRM1—bone cancer	4.94e-05	0.000406	CbGpPWpGaD
Progesterone—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	4.94e-05	0.000405	CbGpPWpGaD
Progesterone—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	4.94e-05	0.000405	CbGpPWpGaD
Progesterone—PGR—Gene Expression—EZH2—bone cancer	4.88e-05	0.0004	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.83e-05	0.000396	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	4.82e-05	0.000395	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.81e-05	0.000394	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—ENO2—bone cancer	4.75e-05	0.00039	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—NDUFA12—bone cancer	4.7e-05	0.000386	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	4.67e-05	0.000384	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—GNA11—bone cancer	4.65e-05	0.000382	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—SMO—bone cancer	4.62e-05	0.000379	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	4.51e-05	0.000371	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	4.51e-05	0.000371	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—TP53—bone cancer	4.5e-05	0.000369	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—RGS1—bone cancer	4.46e-05	0.000366	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—GRM4—bone cancer	4.46e-05	0.000366	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—NR1I2—bone cancer	4.46e-05	0.000366	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	4.44e-05	0.000365	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—DHFR—bone cancer	4.41e-05	0.000362	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—NR1I2—bone cancer	4.39e-05	0.000361	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	4.36e-05	0.000358	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—GSTP1—bone cancer	4.35e-05	0.000357	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.35e-05	0.000357	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—NDUFA12—bone cancer	4.31e-05	0.000354	CbGpPWpGaD
Progesterone—CYP1A2—Biological oxidations—GSTP1—bone cancer	4.28e-05	0.000351	CbGpPWpGaD
Progesterone—AR—Gene Expression—EIF2S1—bone cancer	4.28e-05	0.000351	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—BRAF—bone cancer	4.27e-05	0.000351	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—GNA11—bone cancer	4.22e-05	0.000346	CbGpPWpGaD
Progesterone—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	4.22e-05	0.000346	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—IL3—bone cancer	4.21e-05	0.000346	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.15e-05	0.00034	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—bone cancer	4.13e-05	0.000339	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—NT5C3A—bone cancer	4.13e-05	0.000339	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—GNA11—bone cancer	4.12e-05	0.000338	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—EGFR—bone cancer	4.11e-05	0.000337	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—BRAF—bone cancer	3.98e-05	0.000327	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—ENO2—bone cancer	3.98e-05	0.000327	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—NT5C3A—bone cancer	3.9e-05	0.00032	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—GRM1—bone cancer	3.87e-05	0.000318	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—NDUFA12—bone cancer	3.85e-05	0.000316	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—IL3—bone cancer	3.83e-05	0.000314	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—ENO2—bone cancer	3.82e-05	0.000313	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—NDUFA12—bone cancer	3.76e-05	0.000308	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—CYP3A4—bone cancer	3.74e-05	0.000307	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.73e-05	0.000306	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.72e-05	0.000305	CbGpPWpGaD
Progesterone—AR—Gene Expression—EZH2—bone cancer	3.71e-05	0.000305	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—DHFR—bone cancer	3.69e-05	0.000303	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—MDM2—bone cancer	3.58e-05	0.000294	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.57e-05	0.000293	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—NT5C3A—bone cancer	3.57e-05	0.000293	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—NDUFA12—bone cancer	3.54e-05	0.000291	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—DHFR—bone cancer	3.54e-05	0.000291	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—NDUFA12—bone cancer	3.51e-05	0.000288	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—SMO—bone cancer	3.48e-05	0.000286	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—TP53—bone cancer	3.47e-05	0.000285	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—GNA11—bone cancer	3.45e-05	0.000283	CbGpPWpGaD
Progesterone—ABCC1—Disease—ENO2—bone cancer	3.42e-05	0.000281	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.42e-05	0.000281	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—GRM4—bone cancer	3.34e-05	0.000275	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—RGS1—bone cancer	3.34e-05	0.000275	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—MDM2—bone cancer	3.34e-05	0.000274	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—GNA11—bone cancer	3.31e-05	0.000272	CbGpPWpGaD
Progesterone—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.3e-05	0.000271	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—EIF2S1—bone cancer	3.29e-05	0.00027	CbGpPWpGaD
Progesterone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.26e-05	0.000267	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—EIF2S1—bone cancer	3.24e-05	0.000266	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—GSTP1—bone cancer	3.19e-05	0.000262	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—NT5C3A—bone cancer	3.19e-05	0.000262	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—GNA11—bone cancer	3.18e-05	0.000261	CbGpPWpGaD
Progesterone—ABCC1—Disease—DHFR—bone cancer	3.18e-05	0.000261	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—CYP3A4—bone cancer	3.13e-05	0.000257	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—NT5C3A—bone cancer	3.11e-05	0.000256	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—CYP3A4—bone cancer	3e-05	0.000246	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—NDUFA12—bone cancer	3e-05	0.000246	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.98e-05	0.000245	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—ATF1—bone cancer	2.96e-05	0.000243	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—NT5C3A—bone cancer	2.93e-05	0.000241	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—NT5C3A—bone cancer	2.91e-05	0.000239	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—GRM1—bone cancer	2.9e-05	0.000238	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL3—bone cancer	2.89e-05	0.000237	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.87e-05	0.000236	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—ENO2—bone cancer	2.87e-05	0.000235	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—EZH2—bone cancer	2.86e-05	0.000235	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—EZH2—bone cancer	2.82e-05	0.000231	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—ENO2—bone cancer	2.77e-05	0.000228	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SMO—bone cancer	2.73e-05	0.000224	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—GSTP1—bone cancer	2.68e-05	0.00022	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—DHFR—bone cancer	2.66e-05	0.000218	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.65e-05	0.000217	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—DHFR—bone cancer	2.57e-05	0.000211	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—GSTP1—bone cancer	2.57e-05	0.000211	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.55e-05	0.00021	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—ENO2—bone cancer	2.5e-05	0.000205	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—ENO2—bone cancer	2.5e-05	0.000205	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—GNA11—bone cancer	2.49e-05	0.000205	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—GNA11—bone cancer	2.49e-05	0.000204	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—NT5C3A—bone cancer	2.49e-05	0.000204	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TGFBR2—bone cancer	2.47e-05	0.000203	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—GNA11—bone cancer	2.4e-05	0.000197	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—ENO2—bone cancer	2.33e-05	0.000191	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IGF1R—bone cancer	2.32e-05	0.000191	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—DHFR—bone cancer	2.32e-05	0.00019	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ATF1—bone cancer	2.32e-05	0.00019	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—DHFR—bone cancer	2.32e-05	0.00019	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NDUFA12—bone cancer	2.31e-05	0.00019	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.3e-05	0.000189	CbGpPWpGaD
Progesterone—ABCC1—Disease—TGFBR2—bone cancer	2.3e-05	0.000189	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—ENO2—bone cancer	2.29e-05	0.000188	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL3—bone cancer	2.26e-05	0.000186	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—PTGS2—bone cancer	2.25e-05	0.000185	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—CYP3A4—bone cancer	2.25e-05	0.000185	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.24e-05	0.000184	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—CYP3A4—bone cancer	2.18e-05	0.000179	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.17e-05	0.000178	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—GNA11—bone cancer	2.17e-05	0.000178	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—GNA11—bone cancer	2.16e-05	0.000178	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—DHFR—bone cancer	2.16e-05	0.000177	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—DHFR—bone cancer	2.13e-05	0.000174	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SMO—bone cancer	2.04e-05	0.000168	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—GNA11—bone cancer	2.02e-05	0.000166	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—GNA11—bone cancer	1.99e-05	0.000163	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—CYP3A4—bone cancer	1.97e-05	0.000161	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—CYP3A4—bone cancer	1.96e-05	0.000161	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TGFBR2—bone cancer	1.93e-05	0.000159	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—GSTP1—bone cancer	1.93e-05	0.000158	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NT5C3A—bone cancer	1.92e-05	0.000157	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—GNA11—bone cancer	1.87e-05	0.000153	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—GSTP1—bone cancer	1.86e-05	0.000153	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—CYP3A4—bone cancer	1.83e-05	0.00015	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IGF1R—bone cancer	1.82e-05	0.000149	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.81e-05	0.000149	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ENO2—bone cancer	1.81e-05	0.000148	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CYP3A4—bone cancer	1.8e-05	0.000148	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ATF1—bone cancer	1.74e-05	0.000143	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ENO2—bone cancer	1.71e-05	0.00014	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL3—bone cancer	1.69e-05	0.000139	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KIT—bone cancer	1.68e-05	0.000138	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—GSTP1—bone cancer	1.68e-05	0.000138	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—GSTP1—bone cancer	1.68e-05	0.000138	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—DHFR—bone cancer	1.68e-05	0.000138	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PTGS2—bone cancer	1.66e-05	0.000136	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—DHFR—bone cancer	1.58e-05	0.00013	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—BRAF—bone cancer	1.58e-05	0.00013	CbGpPWpGaD
Progesterone—ABCC1—Disease—KIT—bone cancer	1.57e-05	0.000129	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—GNA11—bone cancer	1.57e-05	0.000129	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ENO2—bone cancer	1.57e-05	0.000128	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—GSTP1—bone cancer	1.56e-05	0.000128	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—GSTP1—bone cancer	1.54e-05	0.000126	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.52e-05	0.000125	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—GNA11—bone cancer	1.48e-05	0.000122	CbGpPWpGaD
Progesterone—ABCC1—Disease—BRAF—bone cancer	1.48e-05	0.000121	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—DHFR—bone cancer	1.45e-05	0.000119	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TGFBR2—bone cancer	1.45e-05	0.000119	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CYP3A4—bone cancer	1.42e-05	0.000117	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ENO2—bone cancer	1.4e-05	0.000115	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PTGS2—bone cancer	1.39e-05	0.000114	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ENO2—bone cancer	1.36e-05	0.000112	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IGF1R—bone cancer	1.36e-05	0.000112	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GNA11—bone cancer	1.36e-05	0.000111	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CYP3A4—bone cancer	1.34e-05	0.00011	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.34e-05	0.00011	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PTGS2—bone cancer	1.33e-05	0.000109	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MDM2—bone cancer	1.33e-05	0.000109	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KIT—bone cancer	1.32e-05	0.000108	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—DHFR—bone cancer	1.3e-05	0.000106	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ENO2—bone cancer	1.29e-05	0.000105	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ENO2—bone cancer	1.27e-05	0.000105	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—DHFR—bone cancer	1.27e-05	0.000104	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—BRAF—bone cancer	1.24e-05	0.000102	CbGpPWpGaD
Progesterone—ABCC1—Disease—MDM2—bone cancer	1.24e-05	0.000101	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CYP3A4—bone cancer	1.23e-05	0.000101	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.22e-05	0.0001	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—GSTP1—bone cancer	1.21e-05	9.97e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GNA11—bone cancer	1.21e-05	9.94e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—EGFR—bone cancer	1.2e-05	9.87e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—DHFR—bone cancer	1.19e-05	9.78e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTGS2—bone cancer	1.19e-05	9.78e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GNA11—bone cancer	1.18e-05	9.7e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—DHFR—bone cancer	1.18e-05	9.7e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—JUN—bone cancer	1.15e-05	9.46e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—GSTP1—bone cancer	1.15e-05	9.42e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MMP9—bone cancer	1.12e-05	9.21e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GNA11—bone cancer	1.11e-05	9.14e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GNA11—bone cancer	1.1e-05	9.07e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CYP3A4—bone cancer	1.1e-05	9.01e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.09e-05	8.97e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ENO2—bone cancer	1.09e-05	8.94e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CYP3A4—bone cancer	1.07e-05	8.8e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GSTP1—bone cancer	1.05e-05	8.64e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MDM2—bone cancer	1.04e-05	8.53e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CYP3A4—bone cancer	1.01e-05	8.29e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—DHFR—bone cancer	1.01e-05	8.29e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CYP3A4—bone cancer	1e-05	8.22e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTGS2—bone cancer	9.98e-06	8.19e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.96e-06	8.18e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KIT—bone cancer	9.89e-06	8.11e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTGS2—bone cancer	9.66e-06	7.93e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GNA11—bone cancer	9.44e-06	7.75e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GSTP1—bone cancer	9.39e-06	7.71e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—BRAF—bone cancer	9.29e-06	7.63e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GSTP1—bone cancer	9.17e-06	7.52e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EGFR—bone cancer	9.07e-06	7.44e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—JUN—bone cancer	9.03e-06	7.41e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MMP9—bone cancer	8.79e-06	7.21e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTGS2—bone cancer	8.71e-06	7.15e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTGS2—bone cancer	8.69e-06	7.14e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTP1—bone cancer	8.64e-06	7.09e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTP1—bone cancer	8.56e-06	7.03e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP3A4—bone cancer	8.56e-06	7.02e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.51e-06	6.99e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—EGFR—bone cancer	8.45e-06	6.94e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ENO2—bone cancer	8.4e-06	6.9e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTGS2—bone cancer	8.1e-06	6.65e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTGS2—bone cancer	7.98e-06	6.55e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—DHFR—bone cancer	7.79e-06	6.4e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MDM2—bone cancer	7.79e-06	6.39e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—bone cancer	7.61e-06	6.25e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTP1—bone cancer	7.32e-06	6.01e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GNA11—bone cancer	7.28e-06	5.98e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EGFR—bone cancer	7.1e-06	5.83e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—JUN—bone cancer	6.77e-06	5.55e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MMP9—bone cancer	6.58e-06	5.4e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTGS2—bone cancer	6.29e-06	5.17e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—bone cancer	5.96e-06	4.89e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTGS2—bone cancer	5.95e-06	4.88e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTP1—bone cancer	5.65e-06	4.64e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTGS2—bone cancer	5.45e-06	4.47e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGFR—bone cancer	5.32e-06	4.37e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTGS2—bone cancer	4.87e-06	3.99e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTGS2—bone cancer	4.75e-06	3.9e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTGS2—bone cancer	4.48e-06	3.67e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—bone cancer	4.47e-06	3.67e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTGS2—bone cancer	4.44e-06	3.64e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTGS2—bone cancer	3.79e-06	3.11e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTGS2—bone cancer	2.93e-06	2.4e-05	CbGpPWpGaD
